Literature DB >> 20019704

Does ACE2 contribute to the development of hypertension?

Mark C Chappell1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20019704      PMCID: PMC3068471          DOI: 10.1038/hr.2009.207

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  19 in total

1.  Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice.

Authors:  Susan B Gurley; Alicia Allred; Thu H Le; Robert Griffiths; Lan Mao; Nisha Philip; Timothy A Haystead; Mary Donoghue; Roger E Breitbart; Susan L Acton; Howard A Rockman; Thomas M Coffman
Journal:  J Clin Invest       Date:  2006-07-27       Impact factor: 14.808

2.  Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II.

Authors:  Hossam A Shaltout; Brian M Westwood; David B Averill; Carlos M Ferrario; Jorge P Figueroa; Debra I Diz; James C Rose; Mark C Chappell
Journal:  Am J Physiol Renal Physiol       Date:  2006-08-08

3.  ACE and ACE2 activity in diabetic mice.

Authors:  Jan Wysocki; Minghao Ye; Maria José Soler; Susan B Gurley; Hong D Xiao; Kenneth E Bernstein; Thomas M Coffman; Sheldon Chen; Daniel Batlle
Journal:  Diabetes       Date:  2006-07       Impact factor: 9.461

4.  Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.

Authors:  Koichi Yamamoto; Mitsuru Ohishi; Tomohiro Katsuya; Norihisa Ito; Masashi Ikushima; Masaharu Kaibe; Yuji Tatara; Atsushi Shiota; Sumio Sugano; Satoshi Takeda; Hiromi Rakugi; Toshio Ogihara
Journal:  Hypertension       Date:  2006-02-27       Impact factor: 10.190

5.  Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells.

Authors:  Fiona J Warner; Rebecca A Lew; A Ian Smith; Daniel W Lambert; Nigel M Hooper; Anthony J Turner
Journal:  J Biol Chem       Date:  2005-09-15       Impact factor: 5.157

6.  Developmental expression of ACE2 in the SHR kidney: a role in hypertension?

Authors:  C Tikellis; M E Cooper; K Bialkowski; C I Johnston; W C Burns; R A Lew; A I Smith; M C Thomas
Journal:  Kidney Int       Date:  2006-05-17       Impact factor: 10.612

7.  Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.

Authors:  Carlos M Ferrario; Jewell Jessup; Mark C Chappell; David B Averill; K Bridget Brosnihan; E Ann Tallant; Debra I Diz; Patricia E Gallagher
Journal:  Circulation       Date:  2005-05-16       Impact factor: 29.690

8.  Renal ACE2 expression and activity is unaltered during established hypertension in adult SHRSP and TGR(mREN2)27.

Authors:  Jelena Kamilic; Inge Hamming; Reinhold Kreutz; Juliane Bolbrinker; Wolf-Eberhard Siems; Ibrahim Nassar; Judith C Sluimer; Thomas Walther; Gerjan J Navis; Harry van Goor
Journal:  Hypertens Res       Date:  2009-11-20       Impact factor: 3.872

9.  Angiotensin-converting enzyme 2 is an essential regulator of heart function.

Authors:  Michael A Crackower; Renu Sarao; Gavin Y Oudit; Chana Yagil; Ivona Kozieradzki; Sam E Scanga; Antonio J Oliveira-dos-Santos; Joan da Costa; Liyong Zhang; York Pei; James Scholey; Carlos M Ferrario; Armen S Manoukian; Mark C Chappell; Peter H Backx; Yoram Yagil; Josef M Penninger
Journal:  Nature       Date:  2002-06-20       Impact factor: 49.962

10.  Angiotensin II formation in the kidney and nephrosclerosis in Ren-2 hypertensive rats.

Authors:  Andrea Hartner; Markus Porst; Bernd Klanke; Nada Cordasic; Roland Veelken; Karl F Hilgers
Journal:  Nephrol Dial Transplant       Date:  2006-03-07       Impact factor: 5.992

View more
  4 in total

1.  Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).

Authors:  Carlos M Ferrario; Sarfaraz Ahmad; Janae Joyner; Jasmina Varagic
Journal:  Adv Pharmacol       Date:  2010

2.  SARS-CoV-2 (COVID-19): Beginning to Understand a New Virus.

Authors:  Giau Van Vo; Eva Bagyinszky; Yoon Soo Park; John Hulme; Seong Soo A An
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies.

Authors:  Girish Pathangey; Priyal P Fadadu; Alexandra R Hospodar; Amr E Abbas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-11-25       Impact factor: 5.464

4.  Possible protective role of 17β-estradiol against COVID-19.

Authors:  Nabab Khan
Journal:  J Allergy Infect Dis       Date:  2020-08-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.